Feed MASI
MA

Masimo

MASI · NASDAQ

$179.95 +0.00% (+$0.00)
Market Cap $9.42B
P/E Ratio -
Div. Yield -
ROE 18.14%

Bulios Fair Price

$94.98

47.2% downside

Current Price

$179.95

Undervalued Fair Value Overvalued

According to Bulios Fair Price, MASI is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
8/9
Valuation
5 /100
Expensive
P/S 6.21x
P/B 11.95x
P/FCF 50.97x
Growth
37 /100
Stable
Rev. growth 21.44%
FCF growth 63.46%
Book val. growth 1.02%
Profitability
67 /100
Strong
Net margin 10.72%
Op. margin 19.99%
FCF margin 12.18%
Quality
47 /100
Average
ROE 18.14%
ROA 9.90%
Asset turnover 0.92x
Debt
85 /100
Low
Current ratio 2.68x
Int. coverage 8.70x
Net debt/EBITDA 0.98x
Stability
49 /100
Moderate
Rev. volatility 34.75%
EPS volatility 20.21%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about MASI
Online

About the company

Masimo Corporation is an American healthcare technology company specializing in the development and manufacturing of advanced monitoring devices and sensors for tracking patient vital signs. The company is primarily known for its technology for non-invasive measurement of blood oxygen levels (SpO2) and other vital parameters, which are crucial in intensive care, anesthesia, and surgeries. Masimo has developed a range of innovative products that improve the accuracy of patient monitoring and contribute to better care in healthcare facilities.

Sector

Healthcare

Industry

Medical - Devices

CEO

Catherine Szyman

Employees

7,500

Headquarters

Irvine

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.